Clinical Trial Update: Clinical Outcomes of Levosimendan Versus Dobutamine Versus Milrinone in Cases With Acute Decompensated Heart Failure With Impaired Renal Function

View source ↗

Summary

Completed clinical trial comparing levosimendan, dobutamine, and milrinone for acute decompensated heart failure with impaired renal function.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiorenal Syndrome
• Decompensated Heart Failure

Drugs mentioned

• Dobutamine (dobutamine)
• Levosimendan (levosimendan)
• Milrinone (milrinone)

Snippet

Sponsor: Ain Shams University | Conditions: Acute Decompensated Heart Failure (ADHF), Cardiorenal Syndrome (CRS) | Status: COMPLETED